Logo image of NRC

NATIONAL RESEARCH CORP (NRC) Stock Fundamental Analysis

USA - NASDAQ:NRC - US6373722023 - Common Stock

13.78 USD
+0.53 (+4%)
Last: 11/4/2025, 8:00:02 PM
13.78 USD
0 (0%)
After Hours: 11/4/2025, 8:00:02 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to NRC. NRC was compared to 100 industry peers in the Health Care Providers & Services industry. NRC scores excellent on profitability, but there are concerns on its financial health. NRC has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year NRC was profitable.
In the past year NRC had a positive cash flow from operations.
Each year in the past 5 years NRC has been profitable.
Each year in the past 5 years NRC had a positive operating cash flow.
NRC Yearly Net Income VS EBIT VS OCF VS FCFNRC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

1.2 Ratios

NRC has a better Return On Assets (12.06%) than 98.00% of its industry peers.
NRC's Return On Equity of 114.31% is amongst the best of the industry. NRC outperforms 100.00% of its industry peers.
NRC has a better Return On Invested Capital (21.73%) than 94.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for NRC is significantly above the industry average of 9.42%.
The last Return On Invested Capital (21.73%) for NRC is well below the 3 year average (37.15%), which needs to be investigated, but indicates that NRC had better years and this may not be a problem.
Industry RankSector Rank
ROA 12.06%
ROE 114.31%
ROIC 21.73%
ROA(3y)22.78%
ROA(5y)24%
ROE(3y)62.21%
ROE(5y)57.67%
ROIC(3y)37.15%
ROIC(5y)35.26%
NRC Yearly ROA, ROE, ROICNRC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50 100 150

1.3 Margins

The Profit Margin of NRC (11.76%) is better than 99.00% of its industry peers.
NRC's Profit Margin has declined in the last couple of years.
NRC's Operating Margin of 19.80% is amongst the best of the industry. NRC outperforms 96.00% of its industry peers.
In the last couple of years the Operating Margin of NRC has declined.
Looking at the Gross Margin, with a value of 62.05%, NRC belongs to the top of the industry, outperforming 82.00% of the companies in the same industry.
In the last couple of years the Gross Margin of NRC has remained more or less at the same level.
Industry RankSector Rank
OM 19.8%
PM (TTM) 11.76%
GM 62.05%
OM growth 3Y-10.18%
OM growth 5Y-5.95%
PM growth 3Y-11.83%
PM growth 5Y-7.25%
GM growth 3Y-2.32%
GM growth 5Y-1.11%
NRC Yearly Profit, Operating, Gross MarginsNRC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

3

2. Health

2.1 Basic Checks

NRC has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for NRC has been reduced compared to 1 year ago.
NRC has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, NRC has a worse debt to assets ratio.
NRC Yearly Shares OutstandingNRC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
NRC Yearly Total Debt VS Total AssetsNRC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

An Altman-Z score of 2.94 indicates that NRC is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.94, NRC is doing good in the industry, outperforming 62.00% of the companies in the same industry.
The Debt to FCF ratio of NRC is 6.89, which is on the high side as it means it would take NRC, 6.89 years of fcf income to pay off all of its debts.
NRC has a Debt to FCF ratio (6.89) which is comparable to the rest of the industry.
NRC has a Debt/Equity ratio of 5.31. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 5.31, NRC is doing worse than 80.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 5.31
Debt/FCF 6.89
Altman-Z 2.94
ROIC/WACC2.42
WACC8.98%
NRC Yearly LT Debt VS Equity VS FCFNRC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 0.53 indicates that NRC may have some problems paying its short term obligations.
The Current ratio of NRC (0.53) is worse than 89.00% of its industry peers.
NRC has a Quick Ratio of 0.53. This is a bad value and indicates that NRC is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.53, NRC is not doing good in the industry: 87.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.53
Quick Ratio 0.53
NRC Yearly Current Assets VS Current LiabilitesNRC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

1

3. Growth

3.1 Past

The earnings per share for NRC have decreased strongly by -36.45% in the last year.
Measured over the past years, NRC shows a decrease in Earnings Per Share. The EPS has been decreasing by -3.70% on average per year.
Looking at the last year, NRC shows a decrease in Revenue. The Revenue has decreased by -3.50% in the last year.
Measured over the past years, NRC shows a small growth in Revenue. The Revenue has been growing by 2.25% on average per year.
EPS 1Y (TTM)-36.45%
EPS 3Y-10.59%
EPS 5Y-3.7%
EPS Q2Q%-22.25%
Revenue 1Y (TTM)-3.5%
Revenue growth 3Y-1.13%
Revenue growth 5Y2.25%
Sales Q2Q%-3.38%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NRC Yearly Revenue VS EstimatesNRC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
NRC Yearly EPS VS EstimatesNRC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2023 0.2 0.4 0.6 0.8 1

3

4. Valuation

4.1 Price/Earnings Ratio

NRC is valuated rather expensively with a Price/Earnings ratio of 19.41.
NRC's Price/Earnings ratio is a bit cheaper when compared to the industry. NRC is cheaper than 69.00% of the companies in the same industry.
NRC is valuated rather cheaply when we compare the Price/Earnings ratio to 26.03, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 19.41
Fwd PE N/A
NRC Price Earnings VS Forward Price EarningsNRC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

67.00% of the companies in the same industry are more expensive than NRC, based on the Enterprise Value to EBITDA ratio.
NRC's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 27.34
EV/EBITDA 11.45
NRC Per share dataNRC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

The excellent profitability rating of NRC may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

NRC has a Yearly Dividend Yield of 4.64%, which is a nice return.
NRC's Dividend Yield is rather good when compared to the industry average which is at 2.49. NRC pays more dividend than 99.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, NRC pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.64%

5.2 History

The dividend of NRC decreases each year by -17.40%.
NRC has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-17.4%
Div Incr Years0
Div Non Decr Years0
NRC Yearly Dividends per shareNRC Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

67.82% of the earnings are spent on dividend by NRC. This is not a sustainable payout ratio.
The Dividend Rate of NRC has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP67.82%
EPS Next 2YN/A
EPS Next 3YN/A
NRC Yearly Income VS Free CF VS DividendNRC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
NRC Dividend Payout.NRC Dividend Payout, showing the Payout Ratio.NRC Dividend Payout.PayoutRetained Earnings

NATIONAL RESEARCH CORP

NASDAQ:NRC (11/4/2025, 8:00:02 PM)

After market: 13.78 0 (0%)

13.78

+0.53 (+4%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-27 2025-10-27/amc
Earnings (Next)02-02 2026-02-02
Inst Owners51.36%
Inst Owner Change-0.32%
Ins Owners9.51%
Ins Owner Change10.19%
Market Cap317.77M
Revenue(TTM)139.10M
Net Income(TTM)16.36M
Analysts45
Price TargetN/A
Short Float %3.71%
Short Ratio4.84
Dividend
Industry RankSector Rank
Dividend Yield 4.64%
Yearly Dividend0.48
Dividend Growth(5Y)-17.4%
DP67.82%
Div Incr Years0
Div Non Decr Years0
Ex-Date09-26 2025-09-26 (0.12)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 19.41
Fwd PE N/A
P/S 2.28
P/FCF 27.34
P/OCF 12.39
P/B 22.2
P/tB N/A
EV/EBITDA 11.45
EPS(TTM)0.71
EY5.15%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.5
FCFY3.66%
OCF(TTM)1.11
OCFY8.07%
SpS6.03
BVpS0.62
TBVpS-2.25
PEG (NY)N/A
PEG (5Y)N/A
Graham Number3.15
Profitability
Industry RankSector Rank
ROA 12.06%
ROE 114.31%
ROCE 28.35%
ROIC 21.73%
ROICexc 22.24%
ROICexgc 73.35%
OM 19.8%
PM (TTM) 11.76%
GM 62.05%
FCFM 8.35%
ROA(3y)22.78%
ROA(5y)24%
ROE(3y)62.21%
ROE(5y)57.67%
ROIC(3y)37.15%
ROIC(5y)35.26%
ROICexc(3y)44.09%
ROICexc(5y)48.46%
ROICexgc(3y)273.96%
ROICexgc(5y)N/A
ROCE(3y)48.46%
ROCE(5y)46%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-21.97%
ROICexc growth 5Y-12.09%
OM growth 3Y-10.18%
OM growth 5Y-5.95%
PM growth 3Y-11.83%
PM growth 5Y-7.25%
GM growth 3Y-2.32%
GM growth 5Y-1.11%
F-Score6
Asset Turnover1.02
Health
Industry RankSector Rank
Debt/Equity 5.31
Debt/FCF 6.89
Debt/EBITDA 2.2
Cap/Depr 200.56%
Cap/Sales 10.09%
Interest Coverage 250
Cash Conversion 74.27%
Profit Quality 71.02%
Current Ratio 0.53
Quick Ratio 0.53
Altman-Z 2.94
F-Score6
WACC8.98%
ROIC/WACC2.42
Cap/Depr(3y)236.79%
Cap/Depr(5y)169.97%
Cap/Sales(3y)9.3%
Cap/Sales(5y)6.92%
Profit Quality(3y)77.54%
Profit Quality(5y)88.07%
High Growth Momentum
Growth
EPS 1Y (TTM)-36.45%
EPS 3Y-10.59%
EPS 5Y-3.7%
EPS Q2Q%-22.25%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.5%
Revenue growth 3Y-1.13%
Revenue growth 5Y2.25%
Sales Q2Q%-3.38%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-27.09%
EBIT growth 3Y-11.19%
EBIT growth 5Y-3.83%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-43.42%
FCF growth 3Y-22.27%
FCF growth 5Y-11.96%
OCF growth 1Y-25.7%
OCF growth 3Y-9.26%
OCF growth 5Y-3.29%

NATIONAL RESEARCH CORP / NRC FAQ

What is the ChartMill fundamental rating of NATIONAL RESEARCH CORP (NRC) stock?

ChartMill assigns a fundamental rating of 4 / 10 to NRC.


What is the valuation status for NRC stock?

ChartMill assigns a valuation rating of 3 / 10 to NATIONAL RESEARCH CORP (NRC). This can be considered as Overvalued.


What is the profitability of NRC stock?

NATIONAL RESEARCH CORP (NRC) has a profitability rating of 8 / 10.


How financially healthy is NATIONAL RESEARCH CORP?

The financial health rating of NATIONAL RESEARCH CORP (NRC) is 3 / 10.


Is the dividend of NATIONAL RESEARCH CORP sustainable?

The dividend rating of NATIONAL RESEARCH CORP (NRC) is 5 / 10 and the dividend payout ratio is 67.82%.